Novartis Lottery for Expensive Drug
--Sharing is Caring--

Novartis Lottery for Expensive Drug- World’s Most Expensive Drug for Free

Novartis, a pharmaceutical company has planned to set up a lottery system for giving away the most expensive drug in the world for free to children.

Zolgensma is a drug for spinal muscular atrophy, a rare genetic disorder that causes children to lose control over their muscles and its treatment costs up to $2.1.

Novartis lottery system for this expensive drug is called a managed access program. For babies under the age of two, living in countries where Zolgensma is not approved, this program would establish a bi-weekly draw in the lottery system, but patient advocates are concerned that picking “lucky” people isn’t the best way to do things.

In this program, until the children are no longer medically eligible, they will simply stay in the program if they are not chosen.

TreatSMA, the British advocacy group describes the program as akin to pick “lucky” kids for receiving the life-saving drug over others and has expressed concern with the Novartis lottery program for the expensive drug.

The group said in a statement that, ” We are yet to be convinced that meeting the unmet medical needs in this severe disease through a health lottery system is an appropriate way or not.”

See Also
Scientists Turn Human Organs Transparent To Study Cellular Structure

The subsidiary that developed the drug, AveXis, said that in the US, the drug was approved by the Food and Drug Administration in May and since then the growing demand for this drug outside the US lead to the initiation of this program.

In around three dozen companies, Novartis is still trying to get the drug registered.

AveXis said that with the advice of a “bioethics advisory committee”, this program was created and the manufacturing constraints are managed. On January 2, the dosage lottery is set to start.

For spinal muscular atrophy, only two drugs are approved in the US. Zolgensma and the other drug is called Spinraza, which needs recurring doses. For the first year, the first costs $750,000 and for each following year, it costs $375,000. Now with this program, such an expensive drug can be got for free through this new lottery system.

SOURCE

Author : Prathibha HC

Upload Your Resume' / CV to BioTecNika Talent Pool

Download This Notification
Perfection is her hobby, Reliability is a synonym, Editing is her passion, Excellence is her Goal, Tactfulness is in her genes, Yellow is her Fav color. Preety is the name of the Professional on whom entire BioTecNika relies when it comes to its website. A Gold Medalist in Biotech from SRM University, Chennai with a 9.9 CGPA ( was awarded the Gold Medal by Honorable Prime Minister of India Shri Narendra Modi , as seen in the pic ), She decided to join forces with BioTecNika to ensure India's largest BioSciences Portal expands its reach to every city in India. She has redesigned the new avatar of BioTecNika from scratch and heads the most dynamic, vibrant and well informed Online Team at Biotecnika Info Labs Pvt Ltd